XML 57 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Note 10 - Equity, Share-based Compensation and Warrants (Details Textual) - $ / shares
3 Months Ended
Apr. 28, 2022
Mar. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total (in shares)   9,703  
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price (in dollars per share)   $ 1.85  
Share-based Compensation Arrangement By Share-based Payment Award Options Forfeitures and Expirations, Weighted Average Remaining Contractual Term (Year)   7 years 8 months 12 days  
Two Resigning Directors [Member] | Subsequent Event [Member]      
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares) 348,721    
The Warrant [Member]      
Class of Warrant or Right, Warrants Expired During Period (in shares)   6,142,980  
Class of Warrant or Right, Expired, Exercise Price (in dollars per share)   $ 0.96  
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)   2 years  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)   1,401,282 1,266,033
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)   224,751  
Restricted Stock Units (RSUs) [Member] | The 2014 Equity Incentive Plan [Member] | Share-Based Payment Arrangement, Employee [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)   4 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)   2,957,545  
Deferred Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)   1,209,092  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)   865,052